Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 81 peer-reviewed journal articles Updated
Pediatric Oncology · Wilms Tumor

Understanding Your Child's Wilms Tumor Diagnosis

At a Glance

Wilms tumor, or nephroblastoma, is the most common pediatric kidney cancer and is highly curable, with survival rates exceeding 90%. Treatment is highly standardized based on the tumor's stage and histology, usually beginning with surgical removal of the affected kidney.

Receiving a diagnosis of Wilms tumor (also known as nephroblastoma) for your child is a heavy and overwhelming experience. It is natural to feel a whirlwind of emotions, but there is reason for great hope. Wilms tumor is a highly treatable and curable form of childhood cancer [1]. In high-resource settings, the overall survival and cure rate for children with this diagnosis now exceeds 90% [2][1].

What is Wilms Tumor?

A Wilms tumor is a type of kidney cancer that begins when cells that were supposed to form the kidney during development do not mature properly [3]. Instead, these “embryonal” cells grow into a mass. It is the most common primary kidney cancer in children, accounting for about 90% of all pediatric kidney malignancies [4][5].

Many parents first notice a hard, swollen belly or blood in the urine. Seeing these symptoms explained by the diagnosis can be both validating and terrifying. These tumors are a well-understood area of pediatric medicine. They are most commonly found in children between the ages of 2 and 5, with the peak incidence occurring around age 3 to 3.5 [6][7]. While it is very common in early childhood, it is extremely rare in adults [7].

Three Critical Facts to Know Now

  1. It is not your fault: In the vast majority of cases, there is nothing a parent did or didn’t do to cause this. While about 10% of children have a genetic predisposition, most cases occur randomly [8][9].
  2. The cure rates are excellent: Modern medicine has turned Wilms tumor into one of the great success stories of pediatric oncology, with 5-year survival rates often exceeding 90% [10][11].
  3. Treatment is highly standardized: Your child’s care will likely follow strict, evidence-based protocols developed by international experts, such as the Children’s Oncology Group (COG) or the International Society of Pediatric Oncology (SIOP) [12][13].

Understanding the Terms You Will Hear

As you speak with the oncology team, you will encounter specific medical terms used to describe the tumor and the treatment plan:

  • Nephrectomy: This is the surgical procedure to remove all or part of the affected kidney [14][15]. Surgery is a cornerstone of treatment for almost every child with a Wilms tumor [13].
  • Histology: This refers to how the tumor cells look under a microscope. This is one of the most important factors in determining treatment [16].
    • Favorable Histology (FH): Most children (about 90%) have this type. It means the cells look more like developing kidney cells and generally respond very well to standard treatment [17][10].
    • Anaplasia (Unfavorable Histology): This means some cells look very distorted or “angry.” If anaplasia is present, doctors will look to see if it is focal (in just one spot) or diffuse (spread throughout the tumor) to decide if more intensive treatment is needed [18][19].
  • Triphasic Tumor: Many Wilms tumors are made of three distinct cell types: blastemal (immature cells), stromal (connective tissue), and epithelial (lining cells) [3][5].
  • Risk Stratification: This is the process doctors use to decide how much treatment your child needs. The goal is to provide enough treatment to cure the cancer while minimizing long-term side effects by avoiding unnecessary radiation or certain types of chemotherapy [20][21].

What Happens Next?

The medical team will focus on “staging” the tumor—determining if it is only in the kidney (Stage I or II) or if it has spread to lymph nodes or other organs (Stage III, IV, or V if both kidneys are involved) [13][19]. This staging, combined with the histology, will form the roadmap for your child’s journey to recovery.

Explore More

01

Biology, Genetics, and Associated Syndromes

Learn about the biological causes and genetics of Wilms tumor. Understand nephrogenic rests, WT1 mutations, and associated syndromes like WAGR and BWSp.

02

Decoding the Pathology Report and Risk Markers

Learn how to read your child's Wilms tumor (nephroblastoma) pathology report. Understand favorable histology, anaplasia, and genetic markers like LOH 1p.

03

Treatment Protocols and Staging (COG vs SIOP)

Understand Wilms tumor treatment protocols. Learn the differences between COG and SIOP, how staging works, and what chemotherapy your child may receive.

04

Surgery, Monitoring, and Life After Wilms Tumor

Learn about life after Wilms tumor treatment. Understand surgery options, living with one kidney, long-term surveillance, and how to manage scanxiety.

Common questions in this guide

What is a Wilms tumor?
A Wilms tumor, also known as nephroblastoma, is the most common type of kidney cancer in children. It develops when immature embryonal cells that were supposed to form the kidney grow into a mass instead.
What does favorable histology mean in a Wilms tumor?
Favorable histology means the tumor cells look more like normal developing kidney cells under a microscope. About 90% of children have this type, which generally responds very well to standard treatments and has excellent outcomes.
What is anaplasia and how does it affect treatment?
Anaplasia refers to tumor cells that look distorted or highly abnormal under a microscope. Depending on whether this anaplasia is focal (found in just one spot) or diffuse (spread throughout the tumor), doctors may recommend a more intensive treatment plan.
What does a triphasic tumor mean?
Many Wilms tumors are triphasic, meaning they are composed of three distinct types of cells: blastemal, stromal, and epithelial. The specific combination and appearance of these cells help pathologists understand the tumor's biology.
Are Wilms tumors curable?
Yes, Wilms tumor is highly treatable and is considered one of the great success stories in pediatric oncology. With modern, standardized treatment protocols, the overall survival and cure rate exceeds 90 percent.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child have 'favorable histology' or 'anaplastic' histology?
  2. 2.Is the anaplasia focal (limited to one spot) or diffuse (spread throughout the tumor)?
  3. 3.What is the stage of my child's tumor (Stage I through V), and how was that determined?
  4. 4.Will my child's treatment plan follow the Children's Oncology Group (COG) or the SIOP protocol?
  5. 5.Does my child have any molecular markers, like '1p/16q loss' or '1q gain,' that will change the treatment intensity?
  6. 6.Is my child's tumor 'triphasic,' and which cell type (blastemal, stromal, or epithelial) is most dominant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Evidence-based surgical guidelines for treating children with Wilms tumor in low-resource settings.

    Abdelhafeez AH, Reljic T, Kumar A, et al.

    Pediatric blood & cancer 2022; (69(12)):e29906 doi:10.1002/pbc.29906.

    PMID: 35929184
  2. 2

    [Wilms' tumour: A review of 15 years recent experience].

    Illade L, Hernandez-Marques C, Cormenzana M, et al.

    Anales de pediatria 2018; (88(3)):140-149 doi:10.1016/j.anpedi.2017.03.019.

    PMID: 28479004
  3. 3

    Novel concept of Wilms' tumor development: involvement of pluripotential cells of ureteric bud.

    Sarkany B, Kuthi L, Kovacs G

    Human pathology 2023; (138()):34-40 doi:10.1016/j.humpath.2023.05.004.

    PMID: 37209922
  4. 4

    Global Disparities in Wilms Tumor.

    Cunningham ME, Klug TD, Nuchtern JG, et al.

    The Journal of surgical research 2020; (247()):34-51 doi:10.1016/j.jss.2019.10.044.

    PMID: 31810638
  5. 5

    Wilms' tumor in a 51-year-old patient: An extremely rare case and review of the literature.

    Hu J, Jin LU, He T, et al.

    Molecular and clinical oncology 2016; (4(6)):1013-1016 doi:10.3892/mco.2016.839.

    PMID: 27313862
  6. 6

    A rare case of a Wilms tumor: case report.

    Singer CE, Marinău LD, Coşoveanu CS, et al.

    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2018; (59(4)):1287-1292.

    PMID: 30845314
  7. 7

    Wilms' Tumour in an Adult- A Case Report of an Unusual Lesion.

    Bera G, Ara Z, Sengupta M, et al.

    Journal of clinical and diagnostic research : JCDR 2017; (11(8)):ED11-ED12 doi:10.7860/JCDR/2017/22957.10383.

    PMID: 28969145
  8. 8

    Case Report: Autosomal dominant polycystic kidney disease and Wilms' tumor in infancy and childhood.

    Zina D, Rosita K, Kristina Z, et al.

    Frontiers in pediatrics 2024; (12()):1322142 doi:10.3389/fped.2024.1322142.

    PMID: 38577638
  9. 9

    Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor.

    Wegert J, Appenzeller S, Treger TD, et al.

    Genome medicine 2025; (17(1)):49 doi:10.1186/s13073-025-01482-0.

    PMID: 40340749
  10. 10

    Children's Oncology Group's 2023 blueprint for research: Renal tumors.

    Geller JI, Hong AL, Vallance KL, et al.

    Pediatric blood & cancer 2023; (70 Suppl 6()):e30586 doi:10.1002/pbc.30586.

    PMID: 37477907
  11. 11

    Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

    Dome JS, Mullen EA, Dix DB, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2021; (19(8)):978-985.

    PMID: 34416705
  12. 12

    [Teratoid Wilms tumor in an adult: A case report].

    Hernández-Marchena YN, González-Medina WE, Bolado-García PB, et al.

    Revista medica del Instituto Mexicano del Seguro Social 2026; (64(1)):e6762 doi:10.5281/zenodo.17477324.

    PMID: 41417941
  13. 13

    Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Balis F, Green DM, Anderson C, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2021; (19(8)):945-977.

    PMID: 34416707
  14. 14

    The learning curve for modified hand-assisted retroperitoneoscopic living donor nephrectomy.

    Shang L, Zheng M, Wang Z, Zhu Y

    BMC urology 2024; (24(1)):191 doi:10.1186/s12894-024-01581-x.

    PMID: 39227858
  15. 15

    Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

    Yanagisawa T, Schmidinger M, Kawada T, et al.

    European urology focus 2023; (9(2)):275-277 doi:10.1016/j.euf.2023.01.022.

    PMID: 36775716
  16. 16

    Analysis of prognostic factors and development of a predictive model following radical nephrectomy for Wilms tumor in children.

    Teng H, Hou B, Shi K, et al.

    Oncology letters 2025; (30(5)):506 doi:10.3892/ol.2025.15252.

    PMID: 40949891
  17. 17

    Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.

    Woods AD, Berlow NE, Ortiz MV, et al.

    Pediatric blood & cancer 2022; (69(2)):e29401 doi:10.1002/pbc.29401.

    PMID: 34693628
  18. 18

    Anaplasia in Wilms tumor: A critical review.

    Vujanić GM, Mifsud W

    Pediatric blood & cancer 2024; (71(7)):e31000 doi:10.1002/pbc.31000.

    PMID: 38605554
  19. 19

    Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020).

    Vujanić GM, Mifsud W, Chowdhury T, et al.

    Cancer 2022; (128(8)):1666-1675 doi:10.1002/cncr.34107.

    PMID: 35119702
  20. 20

    Wilms tumor.

    Pater L, Melchior P, Rübe C, et al.

    Pediatric blood & cancer 2021; (68 Suppl 2()):e28257 doi:10.1002/pbc.28257.

    PMID: 32893998
  21. 21

    Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.

    Spreafico F, Biasoni D, Lo Vullo S, et al.

    The Journal of urology 2017; (198(5)):1138-1145 doi:10.1016/j.juro.2017.06.081.

    PMID: 28655531

This page provides educational information about Wilms tumor diagnosis and terminology. Always consult your child's pediatric oncologist for personalized medical advice, staging, and treatment planning.

Get notified when new evidence is published on Nephroblastoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.